chr2-206765747-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001136193.2(FASTKD2):​c.-51A>G variant causes a splice region, 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00914 in 159,928 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0089 ( 11 hom., cov: 31)
Exomes 𝑓: 0.014 ( 2 hom. )

Consequence

FASTKD2
NM_001136193.2 splice_region, 5_prime_UTR

Scores

2
Splicing: ADA: 0.0004047
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.16
Variant links:
Genes affected
FASTKD2 (HGNC:29160): (FAST kinase domains 2) This gene encodes a protein that is localized in the mitochondrial inner compartment and that may play a role in mitochondrial apoptosis. Nonsense mutations have been reported to result in cytochrome c oxidase deficiency. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 2-206765747-A-G is Benign according to our data. Variant chr2-206765747-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 137298.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0089 (1355/152220) while in subpopulation NFE AF= 0.0125 (849/68020). AF 95% confidence interval is 0.0118. There are 11 homozygotes in gnomad4. There are 730 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 11 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FASTKD2NM_001136193.2 linkuse as main transcriptc.-51A>G splice_region_variant, 5_prime_UTR_variant 1/12 ENST00000402774.8 NP_001129665.1
FASTKD2NM_001136194.2 linkuse as main transcriptc.-66A>G 5_prime_UTR_variant 1/12 NP_001129666.1
FASTKD2NM_014929.4 linkuse as main transcriptc.-51+93A>G intron_variant NP_055744.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FASTKD2ENST00000402774.8 linkuse as main transcriptc.-51A>G splice_region_variant, 5_prime_UTR_variant 1/121 NM_001136193.2 ENSP00000385990 P1Q9NYY8-1

Frequencies

GnomAD3 genomes
AF:
0.00892
AC:
1357
AN:
152102
Hom.:
11
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00157
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.00432
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0335
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0125
Gnomad OTH
AF:
0.00670
GnomAD4 exome
AF:
0.0139
AC:
107
AN:
7708
Hom.:
2
Cov.:
4
AF XY:
0.0139
AC XY:
54
AN XY:
3876
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0200
Gnomad4 NFE exome
AF:
0.0154
Gnomad4 OTH exome
AF:
0.0106
GnomAD4 genome
AF:
0.00890
AC:
1355
AN:
152220
Hom.:
11
Cov.:
31
AF XY:
0.00981
AC XY:
730
AN XY:
74420
show subpopulations
Gnomad4 AFR
AF:
0.00156
Gnomad4 AMR
AF:
0.00431
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0335
Gnomad4 NFE
AF:
0.0125
Gnomad4 OTH
AF:
0.00664
Alfa
AF:
0.0115
Hom.:
2
Bravo
AF:
0.00631
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxMar 21, 2013This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 23, 2017- -
not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsMay 06, 2015- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024FASTKD2: BS1, BS2 -
Combined oxidative phosphorylation deficiency 44 Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsJul 29, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.8
DANN
Benign
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00040
dbscSNV1_RF
Benign
0.15
SpliceAI score (max)
0.15
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs116297724; hg19: chr2-207630471; API